Related Experiment Video

Updated: Apr 27, 2026

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells
09:26

Generation of Lymphocytic Microparticles and Detection of their Proapoptotic Effect on Airway Epithelial Cells

Published on: February 20, 2015

8.6K

Involvement of platelet-derived microparticles in tumor progression and thrombosis

Soraya Mezouar1, Diane Mege1, Roxane Darbousset1

  • 1Aix Marseille Université, INSERM UMR-S1076, Marseille, France.

Seminars in Oncology
|July 16, 2014
PubMed

Insights

Platelet-derived microparticles (PMPs) are key indicators of platelet activity and cancer progression. Their levels and composition offer potential as cancer biomarkers, reflecting disease stage and thrombotic risk.

Area of Science:

  • Biomedical Science
  • Oncology
  • Hematology

Background:

  • Platelet-derived microparticles (PMPs) are the most common microparticle subtype.
  • PMPs reflect platelet activity, patient physiopathology, and thrombotic status, especially in cancer.
  • Platelets are implicated in cancer progression, metastasis, angiogenesis, and inflammation.

Purpose of the Study:

  • To review PMP generation, composition, and their role in cancer.
  • To explore PMPs' involvement in cancer cell proliferation, interaction, metastasis, angiogenesis, and inflammation.
  • To discuss the clinical relevance and biomarker potential of PMPs in oncology.

Main Methods:

  • Literature review of clinical and experimental studies.
  • Analysis of PMP generation and composition mechanisms.
  • Examination of PMPs' role in cancer and Trousseau syndrome.

Main Results:

  • PMP quantity and composition vary based on generation methods.
  • PMPs are involved in multiple aspects of cancer progression and metastasis.
  • Circulating PMP concentration may correlate with cancer stage.

Conclusions:

  • PMPs are significant in cancer progression and metastasis.
  • PMPs show potential as diagnostic and prognostic biomarkers in cancer.
  • Understanding PMP mechanisms is crucial for clinical applications in oncology.

More Related Videos

Routine Screening Method for Microparticles in Platelet Transfusions09:49

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

16.4K
Ferric Chloride-induced Murine Thrombosis Models10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.9K

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K